These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 5002183)
1. [The problem of drug consumption]. Prof Inferm; 1971; 24(5):155-60. PubMed ID: 5002183 [No Abstract] [Full Text] [Related]
2. [Harmful effects of medicines]. Demers R Union Med Can; 1969 Apr; 98(4):557-9. PubMed ID: 5355786 [No Abstract] [Full Text] [Related]
3. Prognosis of drug consumption. Fikr V; Federmann J Sante Publique (Bucur); 1970; 4():423-37. PubMed ID: 5513287 [No Abstract] [Full Text] [Related]
4. [Registration, collection, and evaluation of drug side effects. Subsequent control necessary for drug security]. Stockhausen J Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):460-3. PubMed ID: 5046056 [No Abstract] [Full Text] [Related]
5. [Pharmacovigilance in the hospital. First results]. Lagier G; Efthymiou ML; Lechat P; Fournier E Therapie; 1974; 29(6):805-10. PubMed ID: 4282425 [No Abstract] [Full Text] [Related]
6. [Responsibility for adverse drug effects]. Naess K Tidsskr Nor Laegeforen; 1971 Mar; 91(9):673-6. PubMed ID: 5576192 [No Abstract] [Full Text] [Related]
7. [Production, control and consumption of drugs in Mexico (preliminary report)]. Heredia Duarte A Salud Publica Mex; 1975; 17(2):169-80. PubMed ID: 1198248 [No Abstract] [Full Text] [Related]
8. [Reports to the Committee of Adverse Drug Reactions]. Juul P Ugeskr Laeger; 1986 May; 148(22):1354-5. PubMed ID: 3727133 [No Abstract] [Full Text] [Related]
9. [Editorial: Reporting of drug side effects]. Gram LF; Pedersen A Ugeskr Laeger; 1975 Jun; 137(23):1270-2. PubMed ID: 1138472 [No Abstract] [Full Text] [Related]
10. [Importance of reporting unexpected drug side effects]. Hamvas J Orv Hetil; 1978 Jun; 119(24):1511. PubMed ID: 662328 [No Abstract] [Full Text] [Related]
11. [Experience in the reporting of adverse reactions to drugs]. Nilsson G Lakartidningen; 1967 May; 64():Suppl 2:49-55. PubMed ID: 5585565 [No Abstract] [Full Text] [Related]
12. [Safety and risk in the drug field: fiction and reality]. Uberla KK MMW Munch Med Wochenschr; 1982 Sep; 124(35):743-6. PubMed ID: 6813703 [No Abstract] [Full Text] [Related]
13. [Possibilities and limits of drug supervision]. Homann G Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116 [No Abstract] [Full Text] [Related]
14. Global opioid consumption: trends, barriers, and diversion. Support Care Cancer; 1995 May; 3(3):159. PubMed ID: 7655774 [No Abstract] [Full Text] [Related]
15. [Drugs and the aged: feasibility of the Health Council recommendations]. Offerhaus L Ned Tijdschr Geneeskd; 1995 Apr; 139(17):869-71. PubMed ID: 7739733 [No Abstract] [Full Text] [Related]
16. Health authorities and drug utilization studies. Garcia Alonso F; Scott AI; Stika L; Westerholm B WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843 [No Abstract] [Full Text] [Related]
17. Impact of drug scheduling on utilization. Holt JM Psychopharmacol Bull; 1981 Jan; 17(1):43-4. PubMed ID: 6894497 [No Abstract] [Full Text] [Related]
18. [4,000 adverse effects of drugs are reported in the Scandinavian countries every year]. Nord Med; 1976 Sep; 91(8-9):209-12. PubMed ID: 967645 [No Abstract] [Full Text] [Related]
19. Prescription drug use and patient education--the critical role of the pharmacist. Lee PR Am J Pharm Educ; 1979; 43(4):354-7. PubMed ID: 10245649 [No Abstract] [Full Text] [Related]
20. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward. Kravitz RL; Bell RA Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573 [No Abstract] [Full Text] [Related] [Next] [New Search]